HLS

HEALIUS FPO [HLS]
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Healthcare · ASX Small Cap
$0.3600 -4.0%

Updated 21 Jul 2026 · Signals refresh every scan

Get alerts when HLS triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track HLS — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Drifting lower — down 10.0% over the last 5 days
  • Volume-price trend suggests distribution — sellers may be sneaking out while price holds
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.2x)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (10% of range)
  • New substantial holder(s) (2)
  • Substantial holder(s) ceased (2)
  • Very high short interest (10.3%)
  • CANSLIM I: Institutional ownership (109%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 53% over the past year
  • Altman Z-Score distress zone (1.40 < 1.81, low-confidence approx)
  • Days to cover very high (23.0)
  • RBA hiking (-3pts)

Risk Signals

  • MACD crossed bearish — momentum is fading
  • Below the 200-day average — the long-term trend is still working against it
  • Negative profit margins (-12%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-2.24%/day)
  • Fading catalyst: strong catalyst but declining momentum
Ask Scout AI about HLS
"What's driving HLS today?" "How does HLS compare to peers?" "Key risks for HLS?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

HIGH Ceasing to be a substantial holder
HIGH Becoming a substantial holder
HIGH Ceasing to be a substantial holder
NONE Change of Director's Interest Notice - Paul Anderson
Announcement tone +3pts

Recent ASX Announcements

2026-07-09 Ceasing to be a substantial holder
2026-07-06 Becoming a substantial holder
2026-07-06 Ceasing to be a substantial holder
2026-07-03 Change of Director's Interest Notice - Paul Anderson
2026-07-03 Becoming a substantial holder

Key Metrics

$272.3M
Market Cap
3.3M
Avg Volume
0.9x
Vol Ratio
$0.30 — $1.07
52-Week Range
10.3%
Short Interest
N/A
Cash Runway
-69.3%
ROE
-12.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 78%
LLeader vs LaggardlaggardRS: -9
IInstitutional SponsorshippassInst: 109%
MMarket DirectionneutralNeutral

Sector: Healthcare

111 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
ECS +20.0%VHL -15.4%NTI +12.5%PIQ -11.4%OSL -10.3%
Compare:HLS vs ECSHLS vs VHLHLS vs NTI
Scout Pro — Deeper Analysis for HLS
Try Pro free for 30 days
Share this analysis

Track HLS and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required